202 related articles for article (PubMed ID: 10632338)
1. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
Fielding P; Turnbull L; Prime W; Walshaw M; Field JK
Clin Cancer Res; 1999 Dec; 5(12):4048-52. PubMed ID: 10632338
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
[TBL] [Abstract][Full Text] [Related]
3. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
[TBL] [Abstract][Full Text] [Related]
4. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
5. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Zhou J; Nong L; Wloch M; Cantor A; Mulshine JL; Tockman MS
Lung Cancer; 2001 Dec; 34(3):341-50. PubMed ID: 11714531
[TBL] [Abstract][Full Text] [Related]
6. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
Zhou J; Mulshine JL; Ro JY; Avis I; Yu R; Lee JJ; Morice R; Lippman SM; Lee JS
Clin Cancer Res; 1998 Jul; 4(7):1631-40. PubMed ID: 9676837
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4.
Zhou J; Mulshine JL; Unsworth EJ; Scott FM; Avis IM; Vos MD; Treston AM
J Biol Chem; 1996 May; 271(18):10760-6. PubMed ID: 8631886
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
10. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma.
Goto Y; Sueoka E; Chiba H; Fujiki H
Jpn J Cancer Res; 1999 Dec; 90(12):1358-63. PubMed ID: 10665654
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
Zhou J; Allred DC; Avis I; MartÃnez A; Vos MD; Smith L; Treston AM; Mulshine JL
Breast Cancer Res Treat; 2001 Apr; 66(3):217-24. PubMed ID: 11510693
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis.
Matsuyama S; Goto Y; Sueoka N; Ohkura Y; Tanaka Y; Nakachi K; Sueoka E
Jpn J Cancer Res; 2000 Jun; 91(6):658-63. PubMed ID: 10874220
[TBL] [Abstract][Full Text] [Related]
14. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
Man YG; Martinez A; Avis IM; Hong SH; Cuttitta F; Venzon DJ; Mulshine JL
Am J Respir Cell Mol Biol; 2000 Nov; 23(5):636-45. PubMed ID: 11062142
[TBL] [Abstract][Full Text] [Related]
15. HnRNP A2/B1 proteins in nontumorous alveolar cells.
Satoh H; Ishikawa H; Kamma H; Yamashita YT; Sekizawa K
Lung; 2003; 181(4):219-25. PubMed ID: 14692562
[TBL] [Abstract][Full Text] [Related]
16. hnRNP B1 expression in benign and malignant lung disease.
Snead DR; Perunovic B; Cullen N; Needham M; Dhillon DP; Satoh H; Kamma H
J Pathol; 2003 May; 200(1):88-94. PubMed ID: 12692846
[TBL] [Abstract][Full Text] [Related]
17. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
Tauler J; Zudaire E; Liu H; Shih J; Mulshine JL
Cancer Res; 2010 Sep; 70(18):7137-47. PubMed ID: 20807810
[TBL] [Abstract][Full Text] [Related]
18. Expression of hnRNP A2/B1 proteins in human cancer cell lines.
Satoh H; Kamma H; Ishikawa H; Horiguchi H; Fujiwara M; Yamashita YT; Ohtsuka M; Sekizawa K
Int J Oncol; 2000 Apr; 16(4):763-7. PubMed ID: 10717246
[TBL] [Abstract][Full Text] [Related]
19. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
Tominaga M; Sueoka N; Irie K; Iwanaga K; Tokunaga O; Hayashi S; Nakachi K; Sueoka E
Lung Cancer; 2003 Apr; 40(1):45-53. PubMed ID: 12660006
[TBL] [Abstract][Full Text] [Related]
20. Correspondence re: M.S. Tockman et al., Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res., 3: 2237-2246, 1997.
Tammemagi CM
Clin Cancer Res; 2000 Apr; 6(4):1601-3. PubMed ID: 10778995
[No Abstract] [Full Text] [Related]
[Next] [New Search]